Joanna E. Burdette

6.6k total citations
182 papers, 4.8k citations indexed

About

Joanna E. Burdette is a scholar working on Molecular Biology, Reproductive Medicine and Pharmacology. According to data from OpenAlex, Joanna E. Burdette has authored 182 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 42 papers in Reproductive Medicine and 39 papers in Pharmacology. Recurrent topics in Joanna E. Burdette's work include Ovarian cancer diagnosis and treatment (36 papers), Microbial Natural Products and Biosynthesis (34 papers) and Reproductive Biology and Fertility (31 papers). Joanna E. Burdette is often cited by papers focused on Ovarian cancer diagnosis and treatment (36 papers), Microbial Natural Products and Biosynthesis (34 papers) and Reproductive Biology and Fertility (31 papers). Joanna E. Burdette collaborates with scholars based in United States, Jordan and Vietnam. Joanna E. Burdette's co-authors include Teresa K. Woodruff, Judy L. Bolton, Daniel D. Lantvit, Richard B. van Breemen, Matthew Dean, Norman R. Farnsworth, John M. Pezzuto, Shelby M. King, A. Douglas Kinghorn and Julie Kim and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and ACS Nano.

In The Last Decade

Joanna E. Burdette

177 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna E. Burdette United States	36	2.2k	849	632	550	538	182	4.8k
Tea Lanišnik Rižner Slovenia	39	1.7k 0.8×	1.1k 1.2×	165 0.3×	339 0.6×	1.1k 2.0×	166	4.6k
Francesca De Amicis Italy	35	1.5k 0.7×	238 0.3×	234 0.4×	683 1.2×	665 1.2×	89	3.5k
Yoav Sharoni Israel	37	2.0k 0.9×	299 0.4×	269 0.4×	270 0.5×	515 1.0×	90	4.0k
Nadeem Siddiqui India	44	3.0k 1.4×	419 0.5×	120 0.2×	539 1.0×	204 0.4×	183	6.3k
Jingling Jin United States	31	1.8k 0.8×	287 0.3×	87 0.1×	423 0.8×	302 0.6×	89	3.2k
Zhongliang Jiang China	32	1.4k 0.6×	525 0.6×	71 0.1×	279 0.5×	263 0.5×	87	2.9k
Adele Chimento Italy	33	955 0.4×	363 0.4×	106 0.2×	308 0.6×	785 1.5×	61	2.8k
Mauro Piantelli Italy	44	2.7k 1.2×	97 0.1×	650 1.0×	1.6k 3.0×	577 1.1×	180	6.3k
Jeong‐Hyung Lee South Korea	32	2.3k 1.1×	274 0.3×	208 0.3×	376 0.7×	164 0.3×	103	3.6k
Durga Prasad Mishra India	28	1.2k 0.5×	293 0.3×	109 0.2×	413 0.8×	167 0.3×	61	2.4k

Countries citing papers authored by Joanna E. Burdette

Since Specialization

Citations

This map shows the geographic impact of Joanna E. Burdette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna E. Burdette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna E. Burdette more than expected).

Fields of papers citing papers by Joanna E. Burdette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna E. Burdette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna E. Burdette. The network helps show where Joanna E. Burdette may publish in the future.

Co-authorship network of co-authors of Joanna E. Burdette

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna E. Burdette. A scholar is included among the top collaborators of Joanna E. Burdette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna E. Burdette. Joanna E. Burdette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rayamajhi, Sagar, Leonidas E. Bantis, Rashna Madan, et al.. (2025). Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles. Cancer Research Communications. 5(8). 1266–1281.

Trinh, Dieu-Thuong Thi, Jiawei Huo, Shan He, et al.. (2025). Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization. Nature Communications. 16(1). 4578–4578. 4 indexed citations

Ren, Yulin, Yue Liu, Kongmany Sydara, et al.. (2025). Cytotoxic and Noncytotoxic Steroidal Constituents of Cryptolepis dubia. Journal of Natural Products. 88(1). 183–190.

Ayon, Navid J., Fatma Ayaloglu Butun, Matthew T. Robey, et al.. (2024). Bioactivity-driven fungal metabologenomics identifies antiproliferative stemphone analogs and their biosynthetic gene cluster. Metabolomics. 20(5). 90–90. 5 indexed citations

King, Christina D., Jacob Rose, Joanna E. Burdette, et al.. (2023). Proteomic quantification of native and ECM-enriched mouse ovaries reveals an age-dependent fibro-inflammatory signature. Aging. 15(20). 10821–10855. 22 indexed citations

Rayamajhi, Sagar, Angela Russo, Harsh B. Pathak, et al.. (2023). Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System. Bioengineering. 10(4). 423–423. 13 indexed citations

Ren, Yulin, Lei Tian, Sijin Wu, et al.. (2023). The Cytotoxic Cardiac Glycoside (−)-Cryptanoside A from the Stems ofCryptolepis dubiaand Its Molecular Targets. Journal of Natural Products. 86(6). 1411–1419. 7 indexed citations

Colby, Aaron H., Amit Patwa, Rong Liu, et al.. (2023). Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation. ACS Nano. 17(3). 2212–2221. 11 indexed citations

Bazioli, Jaqueline Moraes, Daniel D. Lantvit, Samuel K. Kulp, et al.. (2023). Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models. Molecular Pharmaceutics. 20(6). 3049–3059. 3 indexed citations

10.

Rodriguez, Galaxia M., et al.. (2022). The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research. Cancer Research Communications. 2(6). 417–433. 15 indexed citations

11.

Young, Alexandria N., Melissa R. Pergande, A. Douglas Kinghorn, et al.. (2022). PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death and Disease. 13(1). 45–45. 25 indexed citations

12.

Aldrich, Leslie N., Joanna E. Burdette, Esperanza J. Carcache de Blanco, et al.. (2022). Discovery of Anticancer Agents of Diverse Natural Origin. Journal of Natural Products. 85(3). 702–719. 30 indexed citations

13.

Burdette, Joanna E., et al.. (2021). Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum. Molecular Omics. 17(6). 819–832. 3 indexed citations

14.

Knowles, Sonja L., Christopher D. Roberts, Laura Flores‐Bocanegra, et al.. (2021). Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations. Journal of Natural Products. 84(4). 1254–1260. 8 indexed citations

15.

Russo, Angela, Daniel D. Lantvit, Cedric J. Pearce, et al.. (2020). Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage. Molecular Cancer Therapeutics. 19(1). 89–100. 19 indexed citations

16.

Knowles, Sonja L., Huzefa A. Raja, Laura Flores‐Bocanegra, et al.. (2020). Wheldone: Characterization of a Unique Scaffold from the Coculture of Aspergillus fischeri and Xylaria flabelliformis. Organic Letters. 22(5). 1878–1882. 17 indexed citations

17.

Young, Alexandria N., Daniel D. Lantvit, Christopher C. Coss, et al.. (2018). Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition. Molecular Cancer Therapeutics. 17(10). 2123–2135. 29 indexed citations

18.

Kim, Mijung, Lisa M. Rooper, Jia Xie, et al.. (2012). The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation. Molecular Cancer Research. 10(11). 1419–1429. 41 indexed citations

19.

Burdette, Joanna E. & Teresa K. Woodruff. (2007). Activin and estrogen crosstalk regulates transcription in human breast cancer cells. Endocrine Related Cancer. 14(3). 679–689. 35 indexed citations

20.

Booth, Nancy L., Cassia Overk, Ping Yao, et al.. (2006). The Chemical and Biologic Profile of a Red Clover ( Trifolium pratense L.) Phase II Clinical Extract. The Journal of Alternative and Complementary Medicine. 12(2). 133–139. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact